SOUTH SAN FRANCISCO, Calif., April 09, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, announced today that Richard van den Broek, ...

DETROIT — Yankees outfielder Cody Bellinger was held out of Tuesday’s game against the Tigers, but don’t blame a matchup against fellow lefty Tarik Skubal for that decision. Instead ...

As always, there are some stunning Sci-Fi reveals from the team at Corvus Belli, introducing a bunch of new miniatures to existing factions as well as a variety of new characters to shake things up.

Corvus Belli held a series of seminars throughout AdeptiCon and shared what's coming for their different miniatures games. Warcrow featured and the team showcased some great new miniatures coming out ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Corvus Pharmaceuticals' stock has experienced volatility due to mixed clinical data, particularly from their lead asset soquelitinib's Phase 1 trial in atopic dermatitis. The company has promising ...

The 36th GLAAD Media Awards have concluded in Los Angeles, recognizing achievements across LGBTQ media over the past year. Streaming April 12 on Hulu, the awards show hosted by Michael Urie ...

Stemming from an offseason meeting held by Penske Entertainment where the parent company of the series showed team owners a rendering of the future car that left many feeling underwhelmed and ...

Corvus Pharmaceuticals reported a wider-than-expected loss for the fourth quarter of 2024, with an earnings per share (EPS) of -$0.18, missing analyst forecasts of -$0.12. Following the ...